GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Debt-to-EBITDA

Molekule Group (Molekule Group) Debt-to-EBITDA : -0.50 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Molekule Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $4.86 Mil. Molekule Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $42.30 Mil. Molekule Group's annualized EBITDA for the quarter that ended in Jun. 2023 was $-94.48 Mil. Molekule Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was -0.50.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Molekule Group's Debt-to-EBITDA or its related term are showing as below:

MKULQ' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.15   Med: -0.33   Max: -0.1
Current: -1.15

During the past 4 years, the highest Debt-to-EBITDA Ratio of Molekule Group was -0.10. The lowest was -1.15. And the median was -0.33.

MKULQ's Debt-to-EBITDA is ranked worse than
100% of 2301 companies
in the Industrial Products industry
Industry Median: 1.74 vs MKULQ: -1.15

Molekule Group Debt-to-EBITDA Historical Data

The historical data trend for Molekule Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Debt-to-EBITDA Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Debt-to-EBITDA
-0.57 - - -0.10

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.08 -1.59 -0.50

Competitive Comparison of Molekule Group's Debt-to-EBITDA

For the Pollution & Treatment Controls subindustry, Molekule Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molekule Group's Debt-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Molekule Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Molekule Group's Debt-to-EBITDA falls into.



Molekule Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Molekule Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.114 + 1.521) / -17.132
=-0.10

Molekule Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.86 + 42.3) / -94.476
=-0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2023) EBITDA data.


Molekule Group  (OTCPK:MKULQ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Molekule Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Molekule Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Molekule Group (Molekule Group) Business Description

Traded in Other Exchanges
N/A
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.
Executives
Ritankar Pal officer: Chief Operating Officer 10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris officer: Chief Commercial Officer 3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld director C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre 10 percent owner
Seth Levine 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p. 10 percent owner C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell 10 percent owner C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona officer: Chief Executive Officer 10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet director 10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410

Molekule Group (Molekule Group) Headlines